1-1419209-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145210.3(ANKRD65):c.1091G>A(p.Arg364Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000923 in 1,549,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145210.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD65 | NM_001145210.3 | c.1091G>A | p.Arg364Gln | missense_variant | 4/4 | ENST00000537107.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD65 | ENST00000537107.6 | c.1091G>A | p.Arg364Gln | missense_variant | 4/4 | 5 | NM_001145210.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152186Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000186 AC: 28AN: 150746Hom.: 0 AF XY: 0.000236 AC XY: 19AN XY: 80640
GnomAD4 exome AF: 0.0000945 AC: 132AN: 1397508Hom.: 0 Cov.: 31 AF XY: 0.000113 AC XY: 78AN XY: 689160
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152304Hom.: 0 Cov.: 34 AF XY: 0.0000806 AC XY: 6AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.1091G>A (p.R364Q) alteration is located in exon 4 (coding exon 3) of the ANKRD65 gene. This alteration results from a G to A substitution at nucleotide position 1091, causing the arginine (R) at amino acid position 364 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at